![Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritis. | Semantic Scholar Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92d192da06f9050ad0d4b4d8649d8a09f115eccf/3-Figure3-1.png)
Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritis. | Semantic Scholar
![illustration describing the mechanism of action of abatacept. Abatacept... | Download Scientific Diagram illustration describing the mechanism of action of abatacept. Abatacept... | Download Scientific Diagram](https://www.researchgate.net/profile/Andrew-Ostoer/publication/230769586/figure/fig1/AS:601685726609413@1520464464118/llustration-describing-the-mechanism-of-action-of-abatacept-Abatacept-has-high-affinity.png)
illustration describing the mechanism of action of abatacept. Abatacept... | Download Scientific Diagram
![Abatacept in the treatment of psoriatic arthritis: biological and clinical profiles of the responders | Immunotherapy Abatacept in the treatment of psoriatic arthritis: biological and clinical profiles of the responders | Immunotherapy](https://www.futuremedicine.com/cms/10.2217/imt-2018-0014/asset/images/medium/figure1.gif)
Abatacept in the treatment of psoriatic arthritis: biological and clinical profiles of the responders | Immunotherapy
![Modern approaches to designing novel CD80 inhibitors that mimic biological effects of Abatacept | todaysclinician.com Modern approaches to designing novel CD80 inhibitors that mimic biological effects of Abatacept | todaysclinician.com](https://todaysclinician.com/wp-content/uploads/2016/04/TC-Apr-2016-022-Mechanism-of-T-cell-mediated-interactions.png)
Modern approaches to designing novel CD80 inhibitors that mimic biological effects of Abatacept | todaysclinician.com
![Abatacept, a Novel CD80/86–CD28 T Cell Co‐stimulation Modulator, in the Treatment of Rheumatoid Arthritis - Korhonen - 2009 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library Abatacept, a Novel CD80/86–CD28 T Cell Co‐stimulation Modulator, in the Treatment of Rheumatoid Arthritis - Korhonen - 2009 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c895f7c1-ee0a-48c0-a72e-8edd84e71d12/bcpt_375_f1.gif)
Abatacept, a Novel CD80/86–CD28 T Cell Co‐stimulation Modulator, in the Treatment of Rheumatoid Arthritis - Korhonen - 2009 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
![immunopathology of rheumatoid arthritis and mechanism of abatacept in... | Download Scientific Diagram immunopathology of rheumatoid arthritis and mechanism of abatacept in... | Download Scientific Diagram](https://www.researchgate.net/publication/274275123/figure/fig1/AS:487461123039238@1493231196985/mmunopathology-of-rheumatoid-arthritis-and-mechanism-of-abatacept-in-the-treatment-of.png)
immunopathology of rheumatoid arthritis and mechanism of abatacept in... | Download Scientific Diagram
A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations - Document - Gale Academic OneFile
![Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment | HTML Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment | HTML](https://www.mdpi.com/cells/cells-10-00323/article_deploy/html/images/cells-10-00323-g001.png)
Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment | HTML
![MPs | Free Full-Text | Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications, Subclinical Atherosclerosis | HTML MPs | Free Full-Text | Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications, Subclinical Atherosclerosis | HTML](https://www.mdpi.com/mps/mps-04-00083/article_deploy/html/images/mps-04-00083-g001.png)